GUEST CONTRIBUTOR: Robert H. Press, MD Radiation Oncologist Baptist Health Miami Cancer Institute Conducting high-quality clinical trials is crucial for establishing the value proposition…
A recent study published in JAMA Network Open highlights significant disparities in travel-time access to proton beam therapy (PBT) for cancer treatment across the contiguous United States. Proton beam therapy,…
Congressional Updates Doc Fix Signed Into Law A “mini-bus” federal funding package signed into law March 9 included the “Doctor Fix,” mitigating Medicare physician payment cuts by 1.68% effective March…
NAPT NEWS For Immediate Release: January 23, 2024 – The National Association for Proton Therapy (NAPT), the nation’s leading organization dedicated to increasing patient access to one of the most…
NAPT NEWS For Immediate Release: January 18, 2024 – The National Association for Proton Therapy (NAPT), the nation’s leading organization dedicated to increasing patient access to one of the most…
GUEST CONTRIBUTOR: Mark Pankuch, PhD, DABR, FAAPM Director of Medical Physics Northwestern Medicine - Central DuPage Hospital On January 1, 2024, Illinois saw the…
Building on the groundwork laid in previous years, NAPT continued its aggressive federal advocacy this year. Consistent with NAPT’s mission, its efforts centered on increasing awareness of and support for…
Virginia Attorney General Jason S. Miyares in December issued an opinion confirming that insurers in the Commonwealth are prohibited from denying coverage for proton therapy for cancer treatment when the…
Cancer is a disease where the passage of time can make a difference in treatment outcomes. Recent research underscores the reality that for cancer patients, each week of delay in…
Esophageal cancer incidence in the United States has been on the rise over the past few decades. The American Cancer Society's statistics reveal that in 2022, there were an estimated…
